Regular Articles
Myofibroblast Differentiation Is Induced in Keratinocyte-Fibroblast Co-Cultures and Is Antagonistically Regulated by Endogenous Transforming Growth Factor-β and Interleukin-1

https://doi.org/10.1016/S0002-9440(10)63764-9Get rights and content

In wound healing epidermal-dermal interactions are known to regulate keratinocyte proliferation and differentiation. To find out how fibroblasts respond to epithelial stimuli, we characterized fibroblasts in monolayer co-culture with keratinocytes. On co-culture numerous extracellular matrix- and smooth muscle cell-associated gene transcripts were up-regulated in fibroblasts, suggesting a differentiation into myofibroblasts. Increased α-smooth muscle actin (α-SMA) protein expression in co-cultured fibroblasts started at approximately day 4, was serum-independent, but required endogenous transforming growth factor (TGF)-β. In co-cultures, TGF-β neutralizing monoclonal antibody strongly reduced α-SMA induction. Endogenous TGF-β production and activation were increased at 24 and 48 hours, requiring, like α-SMA induction, close keratinocyte-fibroblast proximity. As myofibroblast differentiation only started after 4 days, we analyzed the presence of endogenous inhibitors at early time points. Blocking keratinocyte-derived interleukin (IL)-1 using IL-1 receptor antagonist, α-SMA expression in co-cultures was potentiated. Conversely, adding exogenous IL-1α completely suppressed endogenous α-SMA induction. In co-cultured fibroblasts strong nuclear factor-κB binding activity was observed from 2 hours, decreasing at 2 and 4 days, suggesting an early, IL-1-mediated inhibition of TGF-β signaling in co-cultured fibroblasts. This biphasic differentiation event is regulated by the balance of endogenous TGF-β and IL-1 activity and is reminiscent of myofibroblast differentiation at early and later stages of wound healing.

Cited by (0)

Supported by grants from the Deutsche Forschungsgemeinschaft, Germany; the Center of Molecular Medicine Cologne, Germany; and the Biotechnology and Biological Sciences Research Council, UK.

Current address of H.S.: Nestlé Research Center, PO Box 44, 1000 Lausanne 26, Switzerland.

View Abstract